Blueprint Medicines News

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director COATS LONNEL

Nov 22 16:51 ET

Blueprint Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(8.5%)

Nov 14 13:29 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.

Nov 12 16:21 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Namouni Fouad

Oct 4 17:14 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.

Sep 11 16:11 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Landsittel Michael

Aug 19 16:03 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Lee Philina

Aug 7 17:12 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Carter Percy H.

Jul 8 19:13 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina

Jul 8 19:13 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra

Jul 8 16:08 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra

Jul 2 16:10 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Durso-Bumpus Debra

Jun 25 16:01 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.

Jun 14 17:45 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director COATS LONNEL

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Beckman Daniella

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Tsai John

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Seely Lynn

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Lydon Nicholas

Jun 14 17:40 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Goldberg Mark Alan

Jun 14 17:35 ET

Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Borisy Alexis

Jun 14 17:35 ET